EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieLeserbriefOpen Access · CC BY 4.0

Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial

Qian Zhou iD, Wenkui Dai, Yanmin Bao, Jing Chen, Xiaohua Han, Changshan Liu, Meijie Hou, Huisheng Yao, Changsuo Hao, Shuaicheng Li iD, Yuejie Zheng

Clinical and Translational Medicine · 2023

DOI: 10.1002/ctm2.1184 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical and Translational Medicine, 2023. Verfasst von Qian Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science, City University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Bacillus licheniformis, Probiotics. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeBacillus licheniformisProbioticsHumansDiarrheaAnti-Bacterial Agents

Stichwörter der Autor:innen

antibiotics-associated diarrheachildrendouble-blind randomized controlled trialgut microbiomeprobiotics

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Computer Science, City University of Hong Kong, Hong Kong, China.
  • Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen, China.
  • Department of Respiratory Diseases, Shenzhen Children's Hospital, Shenzhen, China.
  • Department of Internal Medicine, Shenyang Children's Hospital, Shenyang, China.
  • Department of Paediatrics, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Department of Paediatrics, Shenjing Hospital of China Medical University, Shenyang, China.

ORCID-Profile: Qian Zhou, Shuaicheng Li

Zitieren

APA

Zhou, Q., Dai, W., Bao, Y., Chen, J., Han, X., Liu, C., Hou, M., Yao, H., Hao, C., Li, S., & Zheng, Y. (2023). Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1184

Vancouver

Zhou Q, Dai W, Bao Y, Chen J, Han X, Liu C, et al. Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial. Clinical and Translational Medicine. 2023. doi:10.1002/ctm2.1184

BibTeX
@article{Zhou2023,
  author = {Zhou, Qian and Dai, Wenkui and Bao, Yanmin and Chen, Jing and Han, Xiaohua and Liu, Changshan and Hou, Meijie and Yao, Huisheng and Hao, Changsuo and Li, Shuaicheng and Zheng, Yuejie},
  title = {Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial},
  journal = {Clinical and Translational Medicine},
  year = {2023},
  doi = {10.1002/ctm2.1184}
}
Kostenlos starten →